Cholecystokinin system genes: Associations with panic and other psychiatric disorders

Journal of Affective Disorders

Volumn 136, Issue 3, 2012, Pages 902-908

  Wilson, Julia ^a   Markie, David ^a   Fitches, Alison ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Anxiety disorders; Cholecystokinin; Genetics; Panic disorder

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR;

ADOLESCENT; ADULT; AGED; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COMORBIDITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; PANIC; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SOCIAL PHOBIA;

ADOLESCENT; ADULT; CHOLECYSTOKININ; COHORT STUDIES; COMORBIDITY; HUMANS; MOOD DISORDERS; PANIC DISORDER; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; YOUNG ADULT;

EID: 84857366175     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.09.011     Document Type: Article

References (43)

1. J. Akiyoshi, T. Moriyama, K. Isogawa, M. Miyamoto, I. Sasaki, K. Kuga, H. Yamamoto, K. Yamada, and I. Fujii CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder Journal of Neurochemistry 66 1996 1610 1616
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Association Washington, DC
3. M. Bourin, G.B. Baker, and J. Bradwejn Neurobiology of panic disorder Journal of Psychosomatic Research 44 1998 163 180
4. J. Bradwejn, and D. Koszycki Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients The American Journal of Psychiatry 151 1994 261 263
5. R.C. Carson, J.N. Butcher, and S. Mineka Abnormal Psychology and Modern Life 2000 Allyn and Bacon Boston
6. S.I. Chantarujikapong, J.F. Scherrer, H. Xian, S.A. Eisen, M.J. Lyons, J. Goldberg, M. Tsuang, and W.R. True A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men Psychiatry Research 103 2001 133 145
7. Q. Chen, A. Nakajima, C. Meacham, and Y.P. Tang Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse Proceedings of the National Academy of Sciences of the United States of America 103 2006 3881 3886
8. A. Christoforou, S. Le Hellard, P.A. Thomson, S.W. Morris, A. Tenesa, B.S. Pickard, N.R. Wray, W.J. Muir, D.H. Blackwood, D.J. Porteous, and K.L. Evans Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia Molecular Psychiatry 12 2007 1011 1025
9. C.J. Doughty, J.E. Wells, P.R. Joyce, R.J. Olds, and A.E. Walsh Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings Bipolar Disorders 6 2004 245 252
10. D. Eser, F. di Michele, P. Zwanzger, A. Pasini, T.C. Baghai, C. Schule, R. Rupprecht, and E. Romeo Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers Neuropsychopharmacology 30 2005 192 195
11. S.B. Gabriel, S.F. Schaffner, H. Nguyen, J.M. Moore, J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochner, M. Faggart, S.N. Liu-Cordero, C. Rotimi, A. Adeyemo, R. Cooper, R. Ward, E.S. Lander, M.J. Daly, and D. Altshuler The structure of haplotype blocks in the human genome Science 296 2002 2225 2229
12. M. Gratacos, J. Costas, R. de Cid, M. Bayes, J.R. Gonzalez, E. Baca-Garcia, Y. de Diego, F. Fernandez-Aranda, J. Fernandez-Piqueras, M. Guitart, R. Martin-Santos, L. Martorell, J.M. Menchon, M. Roca, J. Saiz-Ruiz, J. Sanjuan, M. Torrens, M. Urretavizcaya, J. Valero, E. Vilella, X. Estivill, and A. Carracedo Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 150B 2009 808 816
13. S.P. Hamilton, S.L. Slager, L. Helleby, G.A. Heiman, D.F. Klein, S.E. Hodge, M.M. Weissman, A.J. Fyer, and J.A. Knowles No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder Molecular Psychiatry 6 2001 59 65
14. J. Harro CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies Amino Acids 31 2006 215 230
15. E. Hattori, M. Ebihara, K. Yamada, H. Ohba, H. Shibuya, and T. Yoshikawa Identification of a compound short tandem repeat stretch in the 5′-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia Molecular Psychiatry 6 2001 465 470
16. E. Hattori, K. Yamada, T. Toyota, K. Yoshitsugu, M. Toru, H. Shibuya, and T. Yoshikawa Association studies of the CT repeat polymorphism in the 5′ upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects American Journal of Medical Genetics 105 2001 779 782
17. J.M. Hettema, M.C. Neale, and K.S. Kendler A review and meta-analysis of the genetic epidemiology of anxiety disorders The American Journal of Psychiatry 158 2001 1568 1578
18. V.G. Hosing, A. Schirmacher, G. Kuhlenbaumer, C. Freitag, P. Sand, C. Schlesiger, C. Jacob, J. Fritze, P. Franke, M. Rietschel, H. Garritsen, M.M. Nothen, R. Fimmers, F. Stogbauer, and J. Deckert Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder Journal of Neural Transmission. Supplementum 2004 147 156
19. K. Ise, J. Akiyoshi, Y. Horinouchi, T. Tsutsumi, K. Isogawa, and H. Nagayama Association between the CCK-A receptor gene and panic disorder American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 118B 2003 29 31
20. P.R. Joyce, C.J. Doughty, J.E. Wells, A.E. Walsh, A. Admiraal, M. Lill, and R.J. Olds Affective disorders in the first-degree relatives of bipolar probands: results from the South Island Bipolar Study Comprehensive Psychiatry 45 2004 168 174
21. T. Kato, Z.W. Wang, T. Zoega, and R.R. Crowe Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder American Journal of Medical Genetics 67 1996 401 405
22. J.L. Kennedy, J. Bradwejn, D. Koszycki, N. King, R. Crowe, J. Vincent, and O. Fourie Investigation of cholecystokinin system genes in panic disorder Molecular Psychiatry 4 1999 284 285
23. P. Koefoed, D.P. Woldbye, T.O. Hansen, E.S. Hansen, G.M. Knudsen, T.G. Bolwig, and J.F. Rehfeld Gene variations in the cholecystokinin system in patients with panic disorder Psychiatric Genetics 20 2010 59 64
24. N.M. Laird, S. Horvath, and X. Xu Implementing a unified approach to family-based tests of association Genetic Epidemiology 19 Suppl. 1 2000 S36 S42
25. C. Lines, J. Challenor, and M. Traub Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260 British Journal of Clinical Pharmacology 39 1995 235 242
26. R.B. Lydiard Neuropeptides and anxiety: focus on cholecystokinin Clinical Chemistry 40 1994 315 318
27. D.F. MacKinnon, F.J. McMahon, S.G. Simpson, M.G. McInnis, and J.R. DePaulo Panic disorder with familial bipolar disorder Biological Psychiatry 42 1997 90 95
28. D.F. MacKinnon, P.P. Zandi, J. Cooper, J.B. Potash, S.G. Simpson, E. Gershon, J. Nurnberger, T. Reich, and J.R. DePaulo Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder The American Journal of Psychiatry 159 2002 30 35
29. E. Maron, T. Nikopensius, S. Koks, S. Altmae, E. Heinaste, K. Vabrit, V. Tammekivi, P. Hallast, K. Koido, A. Kurg, A. Metspalu, E. Vasar, V. Vasar, and J. Shlik Association study of 90 candidate gene polymorphisms in panic disorder Psychiatric Genetics 15 2005 17 24
30. E. Maron, J.M. Hettema, and J. Shlik Advances in molecular genetics of panic disorder Molecular Psychiatry 15 2010 681 701
31. K. Miyasaka, Y. Yoshida, S. Matsushita, S. Higuchi, O. Shirakawa, H. Shimokata, and A. Funakoshi Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 127 2004 78 80
32. M. Muinos-Gimeno, Y. Espinosa-Parrilla, M. Guidi, B. Kagerbauer, T. Sipila, E. Maron, K. Pettai, L. Kananen, R. Navines, R. Martin-Santos, M. Gratacos, A. Metspalu, I. Hovatta, and X. Estivill Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways Biological Psychiatry 69 2011 526 533
33. B.M. Neale, and P.C. Sham The future of association studies: gene-based analysis and replication American Journal of Human Genetics 75 2004 353 362
34. J.I. Nurnberger Jr.; M.C. Blehar, C.A. Kaufmann, C. York-Cooler, S.G. Simpson, J. Harkavy-Friedman, J.B. Severe, D. Malaspina, and T. Reich Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative Archives of General Psychiatry 51 1994 849 859
35. A. Rotondo, C. Mazzanti, L. Dell'Osso, P. Rucci, P. Sullivan, S. Bouanani, C. Gonnelli, D. Goldman, and G.B. Cassano Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder The American Journal of Psychiatry 159 2002 23 29
36. K.M. Scott, M.A. McGee, M.A. Oakley Browne, and J.E. Wells Mental disorder comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey The Australian and New Zealand Journal of Psychiatry 40 2006 875 881
37. J. Shlik, A. Aluoja, V. Vasar, E. Vasar, T. Podar, and J. Bradwejn Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder Journal of Psychiatry & Neuroscience 22 1997 332 340
38. The International HapMap Consortium A haplotype map of the human genome Nature 437 2005 1299 1320
39. H.J. van Megen, H.G. Westenberg, J.A. den Boer, B. Slaap, and A. Scheepmakers Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks Psychopharmacology (Berl) 129 1997 357 364
40. Z. Wang, J. Valdes, R. Noyes, T. Zoega, and R.R. Crowe Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder American Journal of Medical Genetics 81 1998 228 234
41. K. Yamada, E. Hattori, M. Shimizu, A. Sugaya, H. Shibuya, and T. Yoshikawa Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder Journal of Neural Transmission 108 2001 837 848
42. P. Zwanzger, D. Eser, S. Aicher, C. Schule, T.C. Baghai, F. Padberg, R. Ella, H.J. Moller, and R. Rupprecht Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal- axis activity: a placebo-controlled study Neuropsychopharmacology 28 2003 979 984
43. P. Zwanzger, D. Eser, F. Padberg, T.C. Baghai, C. Schule, R. Rupprecht, F. di Michele, E. Romeo, A. Pasini, and A. Strohle Neuroactive steroids are not affected by panic induction with 50 microg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers Journal of Psychiatric Research 38 2004 215 217